2-morpholino-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

Catalog No. :
ACPABQ567
CAS No. :
1059171-55-9
Molecular Formula :
C18H27BN2O4
Molecular Weight :
346.24

IUPAC Name:2-morpholino-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide

2-morpholino-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$228.00Login to see priceInquiryInquiry
250mg98%$457.00Login to see priceInquiryInquiry
1g98%$914.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-morpholino-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide
IUPAC Name2-morpholino-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide
Molecular FormulaC18H27BN2O4
Molecular Weight346.24
SMILESCC1(C)OB(C2=CC(NC(=O)CN3CCOCC3)=CC=C2)OC1(C)C
InChI KeyDKFMHWKHVHLCII-UHFFFAOYSA-N
Synonym2-morpholino-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetamide;N-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4-morpholineacetamide;4-Morpholineacetamide, N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-
CAS No.1059171-55-9

Synthetic Route by SureRoute

1. ACPABQ567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHZLA740 route compound structure diagram
    ACHZLA740210907-84-9 In Stock
  2. Plus
  3. ACMWYH185 route compound structure diagram
    ACMWYH1853235-69-6 In Stock
  4. Then
  5. ACPABQ567 route product structure diagram
    ACPABQ5671059171-55-9
Inquiry

2. ACPABQ567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPABQ567 route product structure diagram
    ACPABQ5671059171-55-9
Inquiry

Comments (0)